IRF1 and glioblastoma: To determine whether IRF1 plays a role in the regulation of glioblastoma resistance to bevacizumab, glioma cell lines U87 and glioma stem cell-like cells (GSCs) were treated with bevacizumab at different concentrations and the expression of IRF1 was evaluated.